Font Size: a A A

Clinical Features And Prognosis Of Patients With ST-elevation Versus Non-ST-elevation Myocardial Infarction With Non-obstructive Coronary Arteries

Posted on:2022-04-14Degree:MasterType:Thesis
Country:ChinaCandidate:N LiuFull Text:PDF
GTID:2504306332963649Subject:Master of Clinical Medicine (Internal Medicine)
Abstract/Summary:PDF Full Text Request
Objective:In this study,we retrospectively analyzed the clinical data and the occurrence of adverse events after discharge in 196 patients whose coronary angiography suggested non-obstructive coronary artery(normal coronary artery or stenosis <50%)for acute myocardial infarction,The clinical characteristics,prognosis and the risk factors of patients with myocardial infarction with non-coronary arteries(MINOCA)and its subgroups(STEMI group and NSTEMI group)were analyzed to provide reference for clinical work.Methods:The enrolled patients were 196 patients who were diagnosed as MINOCA from January 2015 to July 2018 in the First Hospital of Jilin University.The patient’s baseline clinical data,the medication usage during hospitalization and the occurrence of adverse events after discharge were collected.Statistical analysis was performed using SPSS25.0 software.Continuous variables were evaluated using T test or non-parametric test,Categorical variables were evaluated using the chi-square test,Fisher’s exact test and the log-rank test.Binary Logistic regression analysis was used to evaluated the independent risk factors of poor prognosis in patients with MINOCA and its subgroups.Results:1.The overall clinical characteristics of MINOCA patients: A total of 196 MINOCA patients(2.02%)were included in this study,of which 71.9% were male(141cases)and 28.1% were women(55 cases).The average age of onset was 54.65±11.66 years.The number of days in hospital was 6(4,8).Among the risk factors for coronary heart disease,11.7%(23 cases)with diabetes,48.5%(95 cases)with hypertension,28.6%(56 cases)with hyperlipidemia,8.2%(16 cases)with arrhythmia and 68.9%(135cases)with a history of smoking.There were 14.8%(29 cases)of patients with Killip grade ≥ 2 at the time of admission.2.Prognosis and related risk factors of MINOCA patients: During the follow-up period,a total of 46 patients(23.47%)had 51 adverse events.Binary logistic multivariate regression analysis showed that the patient’s age older than 50 years(HR3.318,Cl 95%: 1.123-9.805,P=0.030)and Killip grade ≥ grade 2(HR 3.053,Cl 95%:1.138-8.189,P= 0.027)were independent risk factors for poor prognosis in MINOCA patients,and the use of β-blockers during hospitalization(HR 0.399,Cl 95%: 0.177-0.902,P=0.027)was an independent protective factor for poor prognosis.In addition,the survival rate of male patients was higher than that of female patients,and the difference was statistically significant(Log-rank P=0.033);Killip≥2 was associated with lower survival rate(Log-rank P=0.013).3.Comparison of clinical features and prognosis between subgroups in MINOCA(STEMI group and NSTEMI group):(1)General information: Among MINOCA patients,the incidence of STEMI was58.7%(115 cases)higher than 41.3%(81 cases)of NSTEMI.The onset age of STEMI patients was lower than NSTEMI patients(52.93±12.68 VS 56.47±11.21,P=0.045).Compared with STEMI patients,the proportion of NSTEMI patients with hypertension and a higher killip grade was higher(P<0.05).In terms of drug use during hospitalization,STEMI group used aspirin more than the NSTEMI group(97.39% VS90.12%,P=0.018),but there was no significant difference in the treatment of Y2P12 blockers,β-blockers,and statins(P>0.05).(2)Laboratory indicators: Compared with the STEMI group,the NSTEMI group had lower levels of prothrombin time,AST,and ALT,while the fasting blood glucose level was higher.The difference between the groups was statistically significant(P<0.05).(3)Prognosis: During the 49(37,61)months of follow-up,the adverse events in the STEMI group was 24.35%(28 cases),including admission to hospital for recurring chest pain 3.48%(4 cases)and recurring myocardial infarction 2.61%(3 cases),heart failure 12.17%(14 cases),stroke 4.35%(5 cases),death 4.35%(5 cases);adverse events in the NSTEMI group were 22.22%(18 cases),incliding admission to hospital for recurring chest pain 4.94%(4 cases),recurring myocardial infarction 2.47%(2cases),heart failure 9.88%(8 cases),stroke 3.70%(3 cases),heart valve replacement2.47%(2 cases),death 1.23%(1 case),there was no statistically significant difference in the incidence of adverse events between the subgroups(P>0.05).(4)Related risk factors of poor prognosis in subgroups: Binary Logistic multivariate regression analysis showed that low-density lipoprotein(HR 3.269,Cl95%: 1.219-8.764,P=0.019)was an independent risk factor for poor prognosis in STEMI patients.The use of β-blockers during hospitalization(HR 0.178,Cl 95%:0.045-0.700,P=0.013)was an independent protective factor for the poor prognosis of STEMI patients;β-blockers used during hospitalization(HR 0.303,Cl 95%: 0.093-0.991,P=0.048)was also a protective factor for poor prognosis of NSTEMI patients.Conclusion:1.The prevalence of MINOCA was low,and it is more common in male patients.The combined risk factors of coronary heart disease were smoking history,history of hypertension,hyperlipidemia,diabetes,and arrhythmia.2.The incidence of prognostic adverse events in MINOCA was relatively high.Age ≥50 years and Killip grade ≥2 were independent risk factors for poor prognosis,and the use of β-blockers during hospitalization was an independent protective factors for poor prognosis.3.The proportion of STEMI in MINOCA patients was higher than NSTEMI,and there was no significant difference in the incidence of adverse events(admission to hospital for recurring chest pain,recurring myocardial infarction,heart failure,stroke,and death)between the two subgroups(P>0.05).4.Different risk factors for poor prognosis in STEMI and NSTEMI groups: Lowdensity lipoprotein was an independent risk factor for poor prognosis in STEMI group,and the use of β-blockers during hospitalization could reduce the risk of adverse events during follow-up in STEMI and NSTEMI groups.
Keywords/Search Tags:myocardial infarction with non-coronary arteries, ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, prognosis, risk factor
PDF Full Text Request
Related items
Clinical Characteristics,treatments And Prognosis In Patients With ST-segment Elevation And Non-ST-segment Elevation Myocardial Infarction With Non-obstructive Coronary Arteries
Comparative Study Of TIMI3Grade Flow After Different Reperfusion Strategies On Myocardial Infarction Size In Patients With Acute ST-segment Elevation Myocardial Infarction
Differential Analysis Of MiRNA-145 Expression Levels In Serum Of Patients With Acute Myocardial Infarction
Effects Of Thrombolysis Followed By Early Percutaneous Coronary Intervention On Myocardial Perfusion In Patients With ST-segment Elevation Myocardial Infarction And The Protective Effects Of Anisodamine On The Myocardial Perfusion And Renal Function
Predictive Factors For The Short-term Prognosis Of ST-segment Elevation Myocardial Infarction
Analysis Of Risk Factors For The Prognosis Of Patients With Non-ST-segment Elevation Myocardial Infarction And Construction And Validation Of Nomogram
Survey On The Early Reperfusion Therapy Status And Prognosis In Patients With Acute ST-segment Elevation Myocardial Infarction In Secondary And Tertiary Hospitals In Hebei Province
Impact Of Admission Hemoglobin Level On One Year Prognosis Of Patients With Acute ST-segment Elevation Myocardial Infarction
The Study About Clinical Prognosis Of The Patients With Non-ST-segment Elevation Myocardial Infarction
10 Value Of MicroRNA-92a For Risk Stratification And Prognosis In The Early Stage Onset Of ST-segment Elevation Myocardial Infarction